Patent
GenNext Technologies announces second US protein footprinting patent
The United States Patent and Trademark Office (USPTO) has issued Patent US 11,181,529 B2: "Radical Dosimetry for the Analysis of Biopharmaceuticals and Bio...
December 10, 2021 | News
How Pfizer boosted security levels across its global manufacturing facilities
Secondly, OT networks are particularly vulnerable because they operate with many proprietary, and often legacy, devices that can be difficult to identify a...
August 18, 2021 | Opinion | By Guilad Regev, SVP Customer Care, Claroty
Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two compa...
July 09, 2021 | News
Alterity Therapeutics granted a new US patent
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...
July 02, 2021 | News
Japan's PMDA enters 8th consecutive year of using Certara’s biosimulation software
Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of&...
June 25, 2021 | News
Zuellig Pharma to advance Cyber-intelligence Capabilities
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...
June 25, 2021 | News
Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan
Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...
June 23, 2021 | News
EYEMATE-SC Biosensor for Remote Glaucoma Care is CE Marked
The patented EYEMATE system is the world’s only clinically-validated product used for comprehensive remote glaucoma monitoring. US FDA Breakthrough D...
June 21, 2021 | News
Orexo continues to strengthen ZUBSOLV´s patent portfolio
The new patents, US Patent Nos. 11,020,387 and 11,020,388, expire in September 2032. Orexo will now have nine patents listed in the Orange Book relati...
June 02, 2021 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
